Caricamento...
An antibody-drug conjugate targeting VpreB1 for the treatment of B-cell acute lymphoblastic leukemia
Abstract: B-lineage acute lymphoblastic leukemia (B-ALL) therapy is being transformed by therapies targeting antigens such as CD19, CD20, and CD22 on the surface of B-ALL cells. Moreover, having therapies targeting these different B-ALL antigens has helped address challenges associated with both int...
Salvato in:
| Autori principali: | , , , , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2025-08-01
|
| Serie: | Blood Neoplasia |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S295032802500055X |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|